1-14 of 14
Allan H. Friedman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

Kristen A. Batich, Elizabeth A. Reap, Gary E. Archer, Luis Sanchez-Perez, Smita K. Nair, Robert J. Schmittling, Pam Norberg, Weihua Xie, James E. Herndon, II, Patrick Healy, Roger E. McLendon, Allan H. Friedman, Henry S. Friedman, Darell Bigner, Gordana Vlahovic, Duane A. Mitchell, John H. Sampson
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (8): 1898–1909.
https://doi.org/10.1158/1078-0432.CCR-16-2057
Published: 13 April 2017
View article titled, Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
Open the PDF for Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination in another window
Includes: Supplementary data
Journal Articles

The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma

James J. Vredenburgh, Annick Desjardins, David A. Reardon, Katherine B. Peters, James E. Herndon, II, Jennifer Marcello, John P. Kirkpatrick, John H. Sampson, Leighann Bailey, Stevie Threatt, Allan H. Friedman, Darell D. Bigner, Henry S. Friedman
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4119–4124.
https://doi.org/10.1158/1078-0432.CCR-11-0120
Published: 15 June 2011
View article titled, The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma
Open the PDF for The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma in another window
Journal Articles

Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme

Jennifer A. Quinn, Sara Xiaoyin Jiang, James Carter, David A. Reardon, Annick Desjardins, James J. Vredenburgh, Jeremy N. Rich, Sridharan Gururangan, Allan H. Friedman, Darell D. Bigner, John H. Sampson, Roger E. McLendon, James E. Herndon, II, Stevie Threatt, Henry S. Friedman
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (3): 1064–1068.
https://doi.org/10.1158/1078-0432.CCR-08-2130
Published: 02 February 2009
View article titled, Phase II Trial of Gliadel plus <em>O</em><sup>6</sup>-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme
Open the PDF for Phase II Trial of Gliadel plus <em>O</em><sup>6</sup>-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme in another window
Journal Articles

Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas

Annick Desjardins, David A. Reardon, James E. Herndon, II, Jennifer Marcello, Jennifer A. Quinn, Jeremy N. Rich, Sith Sathornsumetee, Sridharan Gururangan, John Sampson, Leighann Bailey, Darell D. Bigner, Allan H. Friedman, Henry S. Friedman, James J. Vredenburgh
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (21): 7068–7073.
https://doi.org/10.1158/1078-0432.CCR-08-0260
Published: 03 November 2008
View article titled, Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas
Open the PDF for Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas in another window
Includes: Supplementary data
Journal Articles

Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma

Jill A. Maxwell, Stewart P. Johnson, Roger E. McLendon, David W. Lister, Krystle S. Horne, Ahmed Rasheed, Jennifer A. Quinn, Francis Ali-Osman, Allan H. Friedman, Paul L. Modrich, Darell D. Bigner, Henry S. Friedman
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (15): 4859–4868.
https://doi.org/10.1158/1078-0432.CCR-07-4807
Published: 01 August 2008
View article titled, Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
Open the PDF for Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma in another window
Journal Articles

Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma

James J. Vredenburgh, Annick Desjardins, James E. Herndon, II, Jeannette M. Dowell, David A. Reardon, Jennifer A. Quinn, Jeremy N. Rich, Sith Sathornsumetee, Sridharan Gururangan, Melissa Wagner, Darell D. Bigner, Allan H. Friedman, Henry S. Friedman
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (4): 1253–1259.
https://doi.org/10.1158/1078-0432.CCR-06-2309
Published: 22 February 2007
View article titled, Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma
Open the PDF for Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma in another window
Journal Articles

Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma

David A. Reardon, Jennifer A. Quinn, James J. Vredenburgh, Sridharan Gururangan, Allan H. Friedman, Annick Desjardins, Sith Sathornsumetee, James E. Herndon, II, Jeannette M. Dowell, Roger E. McLendon, James M. Provenzale, John H. Sampson, Robert P. Smith, Alan J. Swaisland, Judith S. Ochs, Peggy Lyons, Sandy Tourt-Uhlig, Darell D. Bigner, Henry S. Friedman, Jeremy N. Rich
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (3): 860–868.
https://doi.org/10.1158/1078-0432.CCR-05-2215
Published: 07 February 2006
View article titled, Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma
Open the PDF for Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma in another window
Journal Articles

Resistance to Tyrosine Kinase Inhibition by Mutant Epidermal Growth Factor Receptor Variant III Contributes to the Neoplastic Phenotype of Glioblastoma Multiforme

Chris A. Learn, Tristan L. Hartzell, Carol J. Wikstrand, Gary E. Archer, Jeremy N. Rich, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner, John H. Sampson
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (9): 3216–3224.
https://doi.org/10.1158/1078-0432.CCR-03-0521
Published: 06 May 2004
View article titled, Resistance to Tyrosine Kinase Inhibition by Mutant Epidermal Growth Factor Receptor Variant III Contributes to the Neoplastic Phenotype of Glioblastoma Multiforme
Open the PDF for Resistance to Tyrosine Kinase Inhibition by Mutant Epidermal Growth Factor Receptor Variant III Contributes to the Neoplastic Phenotype of Glioblastoma Multiforme in another window
Journal Articles

Efficacy of Intracerebral Microinfusion of Trastuzumab in an Athymic Rat Model of Intracerebral Metastatic Breast Cancer

Peter M. Grossi, Hidenobu Ochiai, Gary E. Archer, Roger E. McLendon, Michael R. Zalutsky, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner, John H. Sampson
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (15): 5514–5520.
Published: 03 December 2003
View article titled, Efficacy of Intracerebral Microinfusion of Trastuzumab in an Athymic Rat Model of Intracerebral Metastatic Breast Cancer
Open the PDF for Efficacy of Intracerebral Microinfusion of Trastuzumab in an Athymic Rat Model of Intracerebral Metastatic Breast Cancer in another window
Journal Articles

Epidermal Growth Factor Receptor VIII Peptide Vaccination Is Efficacious against Established Intracerebral Tumors

Amy B. Heimberger, Laura E. Crotty, Gary E. Archer, Kenneth R. Hess, Carol J. Wikstrand, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner, John H. Sampson
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (11): 4247–4254.
Published: 30 September 2003
View article titled, Epidermal Growth Factor Receptor VIII Peptide Vaccination Is Efficacious against Established Intracerebral Tumors
Open the PDF for Epidermal Growth Factor Receptor VIII Peptide Vaccination Is Efficacious against Established Intracerebral Tumors in another window
Journal Articles

Brain Tumors in Mice Are Susceptible to Blockade of Epidermal Growth Factor Receptor (EGFR) with the Oral, Specific, EGFR-Tyrosine Kinase Inhibitor ZD1839 (Iressa)

Amy B. Heimberger, Chris A. Learn, Gary E. Archer, Roger E. McLendon, Tracy A. Chewning, Frank L. Tuck, John B. Pracyk, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner, John H. Sampson
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (11): 3496–3502.
Published: 01 November 2002
View article titled, Brain Tumors in Mice Are Susceptible to Blockade of Epidermal Growth Factor Receptor (EGFR) with the Oral, Specific, EGFR-Tyrosine Kinase Inhibitor ZD1839 (Iressa)
Open the PDF for Brain Tumors in Mice Are Susceptible to Blockade of Epidermal Growth Factor Receptor (EGFR) with the Oral, Specific, EGFR-Tyrosine Kinase Inhibitor ZD1839 (Iressa) in another window
Journal Articles

Temozolomide Delivered by Intracerebral Microinfusion is Safe and Efficacious Against Malignant Gliomas in Rats

Amy B. Heimberger, Gary E. Archer, Roger E. McLendon, Christine Hulette, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner, John H. Sampson
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (10): 4148–4153.
Published: 01 October 2000
View article titled, Temozolomide Delivered by Intracerebral Microinfusion is Safe and Efficacious Against Malignant Gliomas in Rats
Open the PDF for Temozolomide Delivered by Intracerebral Microinfusion is Safe and Efficacious Against Malignant Gliomas in Rats in another window
Journal Articles

Regional Treatment of Epidermal Growth Factor Receptor vIII-expressing Neoplastic Meningitis with a Single-Chain Immunotoxin, MR-1

Gary E. Archer, John H. Sampson, Ian A. J. Lorimer, Roger E. McLendon, Chien-Tsun Kuan, Allan H. Friedman, Henry S. Friedman, Ira H. Pastan, Darell D. Bigner
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2646–2652.
Published: 01 September 1999
View article titled, Regional Treatment of Epidermal Growth Factor Receptor vIII-expressing Neoplastic Meningitis with a Single-Chain Immunotoxin, MR-1
Open the PDF for Regional Treatment of Epidermal Growth Factor Receptor vIII-expressing Neoplastic Meningitis with a Single-Chain Immunotoxin, MR-1 in another window
Journal Articles

Treatment of Neoplastic Meningitis with Intrathecal Temozolomide

John H. Sampson, Gary E. Archer, Alan T. Villavicencio, Roger E. McLendon, Allan H. Friedman, W. Robert Bishop, Darell D. Bigner, Henry S. Friedman
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (5): 1183–1188.
Published: 01 May 1999
View article titled, Treatment of Neoplastic Meningitis with Intrathecal Temozolomide
Open the PDF for Treatment of Neoplastic Meningitis with Intrathecal Temozolomide in another window